Ellen Ordinario is a notable inventor in the field of molecular biology, particularly recognized for her work on gene fusion detection. Her innovative approach focuses on the multiplex detection of actionable gene fusions, which is crucial for advancing cancer diagnostics and treatment.

Latest Patents

Ellen Ordinario holds a patent titled "Multiplex Pcr Detection Of Alk, Ret, And Ros Fusions." This patent provides methods and compositions for the multiplex detection of a large number of actionable gene fusions with very high sensitivity and specificity. The methods can detect ALK, RET, and ROS1 gene fusions, optionally in combination with other mutations and fusions.

Career Highlights

Throughout her career, Ellen has made significant contributions to the field of genetics and molecular diagnostics. Her work has paved the way for more effective cancer treatments by enabling the detection of critical gene fusions that can influence therapeutic decisions.

Collaborations

Ellen has collaborated with esteemed colleagues, including Huan Truong and Dwight Kuo, to enhance the development and application of her innovative detection methods.

Conclusion

Ellen Ordinario's contributions to gene fusion detection represent a significant advancement in molecular diagnostics. Her work not only showcases her expertise but also highlights the importance of innovation in improving healthcare outcomes.

Profile summary based on public USPTO records.